Table 1. Clinician and patient characteristics.
| All encounters (N = 18) | Accepted treatment (N = 7) | Rejected treatment (N = 11) | |
| Clinicians | |||
| Age, mean (SD) | 42.7 (10.3) | 38.1 (10.2) | 45.5 (8.2) |
| Male, n (%) | 12 (67) | 3 (43) | 9 (82) |
| Internal Medicine, n (%) | 14 (77.8) | 6 (85.7) | 8 (72.7) |
| Family Medicine, n (%) | 4 (22.2) | 1 (24.3) | 3 (27.3) |
| Patients | |||
| Age, mean (SD) | 70.6 (9.4) | 71.7 (25.3) | 70.0 (12.3) |
| Prior fracture, n (%) | 12 (67) | 5 (71) | 7 (64) |
| Prior bisphosphonate use, n (%) | 1 (5) | 0 (0) | 1 (9) |
| Estimated 10-year probability of major fragility fractures, mean (SD) | 33.8 (18.8) | 41.4 (25.3) | 28.9 (12.3) |
| Percentage correct answers on bisphosphonate knowledge, mean (SD) | 50.6 (27.0) | 62.6 (22.4) | 43.1 (30.4) |
| Identified own 10-year risk of fracture, n (%) | 10 (55.6) | 3 (43.0) | 7 (63.6) |
| Identified absolute risk reduction in fracture risk with treatment, n (%) | 6 (33.3) | 2 (29.0) | 4 (36.4) |